PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence
2026-08-18T    Biotechnology   Medical/Pharmaceuticals 
Biosolutions could help Japan become a global bioeconomy powerhouse, new report finds
2026-08-18T    Agriculture   Biotechnology   Chemical   Environmental Products & Services 
Enginprime Medical Closes $12M Series A Financing
2026-08-18T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths
2026-08-17T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors
2026-08-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech Announces 2026 Interim Results
2026-08-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
2026-08-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
New Study Confirms Capsugel® Enprotect® Capsules Deliver Robust Gastric Integrity Under Both Fasted and Fed Conditions
2026-08-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics
2026-08-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate
2026-08-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.